BCL9 and eosinophilia-myalgia syndrome: Based on the aforementioned evidence, we hypothesized in the present study that exosomal miR-30c may negatively regulate BCL9 and affect the activity of the Wnt/CD44 signaling pathway, thereby restricting the progression of EMs.